MENU
CYBN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Cybin (CYBN) Ownership - Who owns Cybin?
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues... Show more
Profile
Industry
N/A
Address
100 King Street West
Phone
+1 908 764-8385
Employees
50
Web
https://www.cybin.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
147.7M
P/E Ratio
N/A
Total Cash
136.29M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash/Share
6.48
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CYBN
Capitalization
148M
P/E Ratio
N/A
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash
136M
Total Cash/Share
6.48
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
240M
P/B Ratio
0.84
Cash Flow
N/A
Earnings
-4.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
443M
Current Ratio
12.60
Current Revenue Per Employee
28800.00
Dividends Per Share - Security
N/A
EBITDA
-134.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
23.15
Revenue To Assets
-54.22
Shares Held By Institutions
55.8M
Shares Outstanding - Current
21M
Total Liabilities
13.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-21.542
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 King Street West
Phone
+1 908 764-8385
Employees
50
Web
https://www.cybin.com